office of Drug Evaluation / Food and Drug Administration / Risk Management Advisory Committee / Clinical Reviewer Division of Cardiovascular and Renal Products Clarifying Questions / Drug Safety and Risk Management Advisory Committee / Center for Drug Evaluation and Research / Clinical Reviewer Division of Cardiovascular and Renal Products Issues Affecting Interpretation / Advisory Committee / Cardiovascular and Renal Drugs Advisory Committee / Duke University Medical Center / /
Person
Gary R. Peters / Christopher C. Nessel / A. Michael Lincoff / Allan Coukell / Debra McCall / Kristina Toliver / Scott Emerson / Duke Translational / Remarks Norman Stockbridge / Sanjay Kaul / Preston Dunnmon / Thomas Fleming / Martin Rose / Andrei Kindzelski / Jonathan Fox / Steven Nissen / Norman Stockbridge / Robert M. Califf / Philip Sager / Darren McGuire / Mori Krantz / Kristina A. Toliver / Judith Hochman / Vasilios Papademetriou / /
Position
Director / Division of Cardiovascular and Renal Products / Senior Director / Clinical Research / Chair Acting Committee / Vice President / Cardiovascular Development / Federal Officer / Director / Duke / Director / Vice Chancellor / Major / Chair / Designated Federal Officer / Representative / Director / Clinical Research Johnson & Johnson Pharmaceutical Research / /
Summary Minutes of the Cardiovascular and Renal Drugs Advisory Committee September 8, 2011 Location: UMUC Inn and Conference Center by Marriott, 3501 University Boulevard East, Adelphi, Maryland, 20783 All external reque